mild cognitive impairment

SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients with Mild Alzheimer’s Disease Dementia Purpose The primary objectives are...

Purpose To isolate peripheral blood mononuclear cells (PBMCs), generate induced pluripotent stem cells (iPSCs), and examine phenotypes of Lewy Body Dementia (LBD) patient derived iPSC-neurons. Who can participate...

Placebo-Controlled Trial to Evaluate the Safety & Efficacy of Benfotiamine in Patients with Early Alzheimer’s Disease Purpose To evaluate the safety and efficacy of Benfotiamine in patients with...

A Phase II Clinical Trial for the Assessment of Biomarker Trajectory in Patients withMild Cognitive Impairment Due to Alzheimer’s Disease Treated with Lenalidomide About the Study This study,...

About the Study This study, funded by the State of Arizona Governor’s Office through the American Rescue Plan Act, aims to analyze if long COVID: Eligibility Patients are...